TL
TMRW Life Sciences, Inc.
SEC filingOther Health Care · New York, NY
Amount raised$38.4Msold at filing
Total offering$38.4M
Investors in the raise59count reported to the SEC
FiledApr 24, 2026first sale Mar 26, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Andrew SchwabDirector
Emily Drabant ConleyDirector
Jeffrey PortDirector
Louis VillalbaExecutive Officer, Director
Vinay ShahDirector
William SchoolcraftDirector
Greg EisnerDirector
Executive officers, directors and promoters as listed on the Form D.